Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 6, Page 689-690, September 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: K. ‐F. Liao
,
H.‐C. Lai
,
C.‐L. Lin
,
S.‐W. Lai Source Type: research
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver Cancer | Proton Pump Inhibitors PPIs | Study | Taiwan Health